Side-by-side comparison of AI visibility scores, market position, and capabilities
Houston ultra-low-cost carrier operating from secondary airports with 2.4M customers in 2024 and first break-even year; #1 on-time US airline competing with Allegiant and Frontier for leisure travelers avoiding congested major hubs.
Avelo Airlines is a Houston, Texas-based ultra-low-cost carrier — privately held, founded in 2021 by Andrew Levy (former United Airlines CFO) — operating point-to-point service to leisure destinations from underserved secondary airports (Hollywood Burbank, New Haven, Wilmington, Raleigh-Durham) that avoid the congestion, high fees, and connection banking that characterizes major hub airports, serving 2.4 million customers in 2024 (6 million cumulative since launch) across 47 destinations in 18 US states plus select international routes. Avelo achieved its first break-even full year in 2024 and multiple profitable months, validating the secondary airport ultra-low-cost model in a competitive US aviation market that has seen multiple ULCC failures (Sun Country, Frontier restructurings, Breeze competitive pressure).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.